首页> 美国卫生研究院文献>Translational Andrology and Urology >Utility of cytokeratin 7 S100A1 and caveolin-1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma
【2h】

Utility of cytokeratin 7 S100A1 and caveolin-1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma

机译:细胞角蛋白7S100A1和小窝蛋白1作为免疫组织化学生物标记物区分发色性肾细胞癌与肾肿瘤细胞瘤的效用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundDifferentiation of chromophobe renal cell carcinoma (chRCC) from benign renal oncocytoma (RO) can be challenging especially when there are overlapping histological and morphological features. In this study we have investigated immunohistochemical biomarkers (cytokeratin 7/CK7, Caveolin-1/Cav-1 and S100 calcium-binding protein A1/S100A1) to aid in this difficult differentiation and attempted to validate their use in human renal tumour tissue to assess their discriminatory ability, particularly for chRCC and RO, in an Australian cohort of patients.
机译:背景嗜色性肾细胞癌(chRCC)与良性肾肿瘤细胞瘤(RO)的区别可能具有挑战性,特别是在组织学和形态学特征重叠的情况下。在这项研究中,我们研究了免疫组织化学生物标记物(细胞角蛋白7 / CK7,Caveolin-1 / Cav-1和S100钙结合蛋白A1 / S100A1)来帮助这种困难的分化,并试图验证其在人肾肿瘤组织中的使用,以评估在澳大利亚的患者群体中,它们的辨别能力,特别是对chRCC和RO的辨别能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号